{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:45:34Z","timestamp":1775169934572,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1007\/bf03033371","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:32:17Z","timestamp":1248111137000},"page":"35-43","source":"Crossref","is-referenced-by-count":96,"title":["Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease"],"prefix":"10.1007","volume":"5","author":[{"given":"Manfred","family":"Gerlach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay L.","family":"Double","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorit","family":"Ben-Shachar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussa B. H.","family":"Youdim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03033371_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/1353-8020(96)00004-1","volume":"2","author":"Y Aimi","year":"1996","unstructured":"Aimi Y and PL McGeer (1996) Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons.Parkinson. Relat. Disord.\n                           2, 69\u201374.","journal-title":"Parkinson. Relat. Disord."},{"key":"BF03033371_CR2","first-page":"263","volume":"69","author":"S Aime","year":"1996","unstructured":"Aime S, M Fasano, B Bergamasco, L Lopiano. and G Quattrocolo (1996) Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin.Adv. Neurol.\n                           69, 263\u2013270.","journal-title":"Adv. Neurol."},{"key":"BF03033371_CR3","first-page":"49","volume":"1361","author":"S Aime","year":"1997","unstructured":"Aime S, B Bergamasco, D Biglino, G Digilio, M Fasano, E Giamello and L Lopiano (1997) EPR investigations of the iron domain in neuromelanin.Biochem. Biophys. Acta\n                           1361, 49\u201358.","journal-title":"Biochem. Biophys. Acta"},{"key":"BF03033371_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/1531-8257(200009)15:5<977::AID-MDS1032>3.0.CO;2-Q","volume":"15","author":"S Aime","year":"2000","unstructured":"Aime S, B Bergamasco, M Casu, G Digilio, M Fasano, S Giraudo and L Lopiano (2000) Isolation and13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.Mov. Disord.\n                           15, 977\u2013981.","journal-title":"Mov. Disord."},{"key":"BF03033371_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mds.870130205","volume":"13","author":"RB Banati","year":"1998","unstructured":"Banati RB, SE Daniel and SB Blunt (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.Mov. Disord.\n                           13, 221\u2013227.","journal-title":"Mov. Disord."},{"key":"BF03033371_CR6","first-page":"821","volume":"46","author":"G Bartzokis","year":"2000","unstructured":"Bartzokis G and T Tishler (2000) MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease.Cell. Mol. Biol.\n                           46, 821\u2013833.","journal-title":"Cell. Mol. Biol."},{"key":"BF03033371_CR7","first-page":"251","volume":"29","author":"D Ben-Shachar","year":"1990","unstructured":"Ben-Shachar D and MBH Youdim (1990) Selectivity of melanized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.J. Neural Transm. (Suppl.)\n                           29, 251\u2013258.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03033371_CR8","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1471-4159.1991.tb06358.x","volume":"57","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, P Riederer and MBH Youdim (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease.J. Neurochem.\n                           57, 1609\u20131614.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1471-4159.2001.00608.x","volume":"79","author":"D Berg","year":"2001","unstructured":"Berg D, M Gerlach, MBH Youdim, KL Double, L Zecca, P Riederer and G Becker (2001) Brain iron pathways and their relevance to Parkinson's disease.J. Neurochem.\n                           79, 225\u2013236.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, W Roggendorf, U Schr\u00f6der, R Klein, T Tatschner, P Benz, O Tucha, M Preier, KW Lange, K Reiners, M Gerlach and G Becker (2002) Echogenicity of the substantia nigra. Association with increased iron content and marker for susceptibility to nigrostriatal injury.Arch. Neurol.\n                           59, 999\u20131005.","journal-title":"Arch. Neurol."},{"key":"BF03033371_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, W Birkmayer, O Hornykiewicz, K Jellinger and F Seitelberger (1973) Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations.J. Neurol. Sci.\n                           20, 415\u2013455.","journal-title":"J. Neurol. Sci."},{"key":"BF03033371_CR12","first-page":"15","volume":"46","author":"H Braak","year":"1995","unstructured":"Braak H, E Braak, D Yilmazer, C Schultz, R De Vos and E Jansen (1995) Nigral and extanigral pathology in Parkinson's disease.J. Neural Transm. (Suppl.)\n                           46, 15\u201332.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03033371_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004010050001","volume":"100","author":"R Castellani","year":"2000","unstructured":"Castellani R, S Siedlak, G Perry and M Smith (2000) Sequestration of iron by Lewy bodies in Parkinson's disease.Acta Neuropathol.\n                           100, 111\u2013114.","journal-title":"Acta Neuropathol."},{"key":"BF03033371_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jnr.490310214","volume":"31","author":"JR Connor","year":"1992","unstructured":"Connor JR, BS Snyder, JL Beard, RE Fine and EJ Mufson (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.J. Neurosci. Res.\n                           31, 327\u2013335.","journal-title":"J. Neurosci. Res."},{"key":"BF03033371_CR15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1471-4159.1995.65020717.x","volume":"65","author":"JR Connor","year":"1995","unstructured":"Connor JR, BS Snyder, P Arosio, DA Loeffler and P LeWitt (1995) A quantitative analysis of isoferritins in select regions of aged, parkisonian and Alzheimer's diseased brains.J. Neurochem.\n                           65, 717\u2013724.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1126\/science.3080808","volume":"231","author":"RJ D'Amato","year":"1986","unstructured":"D'Amato RJ, ZP Lipman and SH Snyder (1986) Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP binds to neuromelanin.Science\n                           231, 987\u2013989.","journal-title":"Science"},{"key":"BF03033371_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","volume":"52","author":"P Damier","year":"1993","unstructured":"Damier P, E Hirsch, F Javoy-Agid, P Zhang and Y Agid (1993) Glutathione peroxidase, glial cells and Parkinson's disease.Neuroscience\n                           52, 1\u20136.","journal-title":"Neuroscience"},{"key":"BF03033371_CR18","series-title":"Brain Melanin","volume-title":"Pigments in Pathology","author":"V D'Azur","year":"1786","unstructured":"D'Azur V (1786) Trait\u00e8 d'anatomie et de physiologie. Cited by C.D. Marsden (1969) Brain Melanin, In: Wolman M, Ed.,Pigments in Pathology (Academic Press, New York)."},{"key":"BF03033371_CR19","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, FR Wells, AJ Lees, F Agid, Y Agid, P Jenner and CD Marsden (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.J. Neurochem.\n                           52, 1830\u20131836.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR20","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter, DT, A Carayon, F Javoy-Agid, Y Agid, FR Wells, SE Daniel, A Lees, P Jenner and CD Marsden (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.Brain\n                           114, 1953\u20131975.","journal-title":"Brain"},{"key":"BF03033371_CR21","first-page":"273","volume":"60","author":"D Dexter","year":"1993","unstructured":"Dexter D, J Sian, P Jenner and CD Marsden (1993) Implications of alterations in trace element levels in brain in Parkinson's disease and ther neurological disorders affecting the basal ganglia.Adv. Neurol.\n                           60, 273\u2013281.","journal-title":"Adv. Neurol."},{"key":"BF03033371_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/ana.410350107","volume":"35","author":"D Dexter","year":"1994","unstructured":"Dexter D, J Sian, S Rose, J Hindmarsh, V Mann, J Cooper, F Wells, S Daniel, A Lees and A Schapira (1994) Indices of oxidative stress and mitochondrial function in indiviuals with incidental Lewy body disease.Ann. Neurol.\n                           35, 38\u201344.","journal-title":"Ann. Neurol."},{"key":"BF03033371_CR23","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1046\/j.1471-4159.1998.70062492.x","volume":"70","author":"KL Double","year":"1998","unstructured":"Double KL, M Maywald, M Schmittel, P Riederer and M Gerlach (1998)In vitro studies of ferritin iron release and neurotoxicity.J. Neurochem.\n                           70, 2492\u20132499.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR24","first-page":"333","volume":"12","author":"K Double","year":"1999","unstructured":"Double K, P Riederer and M Gerlach (1999) The significance of neuromelanin in Parkinson's disease.Drug News Develop.\n                           12, 333\u2013340.","journal-title":"Drug News Develop."},{"key":"BF03033371_CR25","first-page":"37","volume":"60","author":"KL Double","year":"2000","unstructured":"Double KL, M Gerlach, MBH Youdim and P Riederer (2000a) Impaired iron homeostatsis in Parkinson's disease.J. Neural Transm. (Suppl.)\n                           60, 37\u201358.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03033371_CR26","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1046\/j.1471-4159.2000.0752583.x","volume":"75","author":"K Double","year":"2000","unstructured":"Double K, L Zecca, P Costo, M Mauer, C Griesinger, S Ito, D Ben-Shachar, G Bringmann, RG Fariello, P Riederer and M Gerlach (2000b)_Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.J. Neurochem.\n                           75, 2583\u20132589.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-1269-1_19","volume-title":"Neurotoxic Factors in Parkinson's Disease and Related Disorder","author":"G Dryhurst","year":"2000","unstructured":"Dryhurst G, X-M Shen, H Li, Z Yang, J Han and F-C Cheng (2000) Potential roles of accelerated dopamine oxidation, altered glutathione metabolism, 5-S-cysteinyl-dopamine and its oxidative metabolism in the pathogenesis of Parkinson's disease. In: Storch A and MA Collins, Eds.,Neurotoxic Factors in Parkinson's Disease and Related Disorder (Kluwer Academic\/Plenum Publishers, New York), pp 181\u2013209."},{"key":"BF03033371_CR28","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H and O Hornykiewicz (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems.Wien. Klin. Wschr.\n                           38, 1236\u20131239.","journal-title":"Wien. Klin. Wschr."},{"key":"BF03033371_CR29","first-page":"97","volume":"58","author":"P Foley","year":"2000","unstructured":"Foley P and P Riederer (2000) The motor circuit of the human basal ganglia reconsidered.J. Neural Transm\n                           58, 97\u2013110.","journal-title":"J. Neural Transm"},{"key":"BF03033371_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1006\/taap.1999.8711","volume":"159","author":"A Fredriksson","year":"1999","unstructured":"Fredriksson A, N Schroder, P Eriksson, I Izquierdo and T Archer (1999) Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice.Toxicol Appl. Pharmacol.\n                           159, 25\u201330.","journal-title":"Toxicol Appl. Pharmacol."},{"key":"BF03033371_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1353-8020(00)00028-6","volume":"7","author":"A Fredriksson","year":"2001","unstructured":"Fredriksson A, N Schroumlautder, P Eriksson, I Izquierdo and T Archer (2001) Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits.Parkinson. Rel. Disord.\n                           7, 97\u2013105.","journal-title":"Parkinson. Rel. Disord."},{"key":"BF03033371_CR32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1471-4159.1994.63030793.x","volume":"63","author":"M Gerlach","year":"1994","unstructured":"Gerlach M, D Ben-Shachar, P Riederer and MBH Youdim (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases?J. Neurochem.\n                           63, 793\u2013807.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1471-4159.1995.65020923.x","volume":"65","author":"M Gerlach","year":"1995","unstructured":"Gerlach M, AX Trautwein, L Zecca, MBH Youdim and P Riederer (1995) M\u00f6ssbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra.J. Neurochem.\n                           65, 923\u2013926.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0006-8993(92)90719-P","volume":"581","author":"W Gibb","year":"1992","unstructured":"Gibb W (1992) Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrastriatal projections and differential neuron susceptibility in Parkinson's disease.Brain. Res.\n                           581, 283\u2013291.","journal-title":"Brain. Res."},{"key":"BF03033371_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0006-8993(92)91334-B","volume":"593","author":"P Good","year":"1992","unstructured":"Good P, W Olanow and D Perl (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.Brain Res.\n                           593, 343\u2013346.","journal-title":"Brain Res."},{"key":"BF03033371_CR36","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.45.6.1138","volume":"45","author":"JM Gorell","year":"1995","unstructured":"Gorell JM, RJ Ordidge, GG Brown, JC Deniau, NM Buderer and JA Helpern (1995) Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease.Neurology\n                           45, 1138\u20131143.","journal-title":"Neurology"},{"key":"BF03033371_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/brain\/122.4.667","volume":"122","author":"PD Griffiths","year":"1999","unstructured":"Griffiths PD, BR Dobson, GR Jones and DT Clarke (1999) Iron in the basal ganglia in Parkinson's disease. Anin vitro study using extended X-ray absorbtin fine structure and cryo-electron microscopy.Brain\n                           122, 667\u2013673.","journal-title":"Brain"},{"key":"BF03033371_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","volume":"1275","author":"PM Harrison","year":"1996","unstructured":"Harrison PM and P Arosio (1996) The ferritins: molecular properties, iron storage function and cellular regulation.Biochem. Biophys. Acta\n                           1275, 161\u2013203.","journal-title":"Biochem. Biophys. Acta"},{"key":"BF03033371_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/10715769900301611","volume":"13","author":"Y He","year":"1999","unstructured":"He Y, T Lee and S Leong (1999) Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning.Free Radic. Res.\n                           13, 103\u2013112.","journal-title":"Free Radic. Res."},{"key":"BF03033371_CR40","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/brain\/123.7.1410","volume":"123","author":"J Henderson","year":"2000","unstructured":"Henderson J, K Carpenter, H Cartwright and G Halliday (2000) Loss of thalamic intralaminar nuclei in progressive supranuclei palsy and Parkinson's disease.Brain\n                           123, 1410\u20131421.","journal-title":"Brain"},{"key":"BF03033371_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, A Graybiel and Y Agid (1988) Melanized dopamine neurons are differentially susceptible to degeneration in Parkinson's disease.Nature\n                           334, 345\u2013348.","journal-title":"Nature"},{"key":"BF03033371_CR42","first-page":"47","volume-title":"Handbook of Experimental Pharmacology, Vol. 88","author":"K Jellinger","year":"1989","unstructured":"Jellinger K (1989) Pathology of Parkinson's syndrome In: Calne DB, Ed.,Handbook of Experimental Pharmacology, Vol. 88 (Springer-Verlag, Berlin Heidelberg), pp 47\u2013112."},{"key":"BF03033371_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"KA Jellinger","year":"1991","unstructured":"Jellinger KA (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.Mol. Chem. Neuropathol.\n                           14, 153\u2013197.","journal-title":"Mol. Chem. Neuropathol."},{"key":"BF03033371_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF02252926","volume":"2","author":"K Jellinger","year":"1990","unstructured":"Jellinger K, W Paulus, I Grundke-Iqbal, P Riederer and MBH Youdim (1990) Brain iron and ferritin in Parkinson's disease and Alzheimer's disease.J. Neural Transm. (P.D.-Sect.)\n                           2, 327\u2013340.","journal-title":"J. Neural Transm. (P.D.-Sect.)"},{"key":"BF03033371_CR45","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1471-4159.1992.tb08362.x","volume":"59","author":"K Jellinger","year":"1992","unstructured":"Jellinger K, E Kienzel, G Rumpelmair, P Riederer, H Stachellberger, D Ben-Shachar and MBH Youdim (1992) Iron-melanin complex in substantia nigra of Parkinsonian brains: an X-ray microanalysis,J. Neurochem.\n                           59, 1168\u20131171.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR46","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","volume":"59","author":"A Kastner","year":"1992","unstructured":"Kastner A, E Hirsch, O Lejeune, F Javoy-Agid O Rascol and Y Agid (1992) Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?J. Neurochem.\n                           59, 1080\u20131089.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0300-483X(00)00231-6","volume":"149","author":"J Kehrer","year":"2000","unstructured":"Kehrer J (2000) The Haber-Weiss reaction and mechanisms of toxicity.Toxicology\n                           149, 43\u201350.","journal-title":"Toxicology"},{"key":"BF03033371_CR48","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0024-3205(99)00458-0","volume":"65","author":"E Kienzl","year":"1999","unstructured":"Kienzl E, K Jellinger, H Stachelberger and W Linert (1999) Iron as a catalyst for oxidative stress in the pathogenesis of Parkinson's disease?Life Sci.\n                           65, 1973\u20131976.","journal-title":"Life Sci."},{"key":"BF03033371_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s100489900083","volume":"2","author":"T Kitada","year":"2000","unstructured":"Kitada T, S Asakawa, H Matsumine, N Hattori, H Shimura, S Minoshima, N Shimizu and Y Mizuno (2000) Progress in the clinical and molecular genetics of familial parkinsonism.Neurogenetics\n                           2, 207\u2013218.","journal-title":"Neurogenetics"},{"key":"BF03033371_CR50","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1021\/tx980114c","volume":"11","author":"ES Krol","year":"1998","unstructured":"Krol ES and DC Liebler (1998) Photoprotective actions of natural and synthetic melanins.Chem. Res. Toxicol.\n                           11, 1434\u20131440.","journal-title":"Chem. Res. Toxicol."},{"key":"BF03033371_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/brain\/123.2.366","volume":"123","author":"N Kubis","year":"2000","unstructured":"Kubis N, B Faucheux, G Ransmayr, P Damier, C Duyckaerts, D Henin, B Forette, Y Le Charpentier, J Hauw, Y Agid and E Hirsch (2000) Preservation of midbrain catecholaminergic neurons in very old human subjects.Brain\n                           123, 366\u2013373. 660.","journal-title":"Brain"},{"key":"BF03033371_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF01277665","volume":"104","author":"J Lan","year":"1997","unstructured":"Lan J and D Jiang (1997a) Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice.J. Neural Transm.\n                           104, 469\u2013481.","journal-title":"J. Neural Transm."},{"key":"BF03033371_CR53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/BF01291883","volume":"104","author":"J Lan","year":"1997","unstructured":"Lan J and D Jiang (1997b) Excessive iron accumulation in the brain: a possible potential source of neurodegeneration in Parkinson's disease.J. Neural Transm.\n                           104, 649","journal-title":"J. Neural Transm."},{"key":"BF03033371_CR54","first-page":"306","volume":"1500","author":"L Lopiano","year":"2000","unstructured":"Lopiano L, M Chiesa, D Digilio, G Giraudo, B Bergamasco and M Fasano (2000) Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients.Biochem. Biophys. Acta\n                           1500, 306\u2013312.","journal-title":"Biochem. Biophys. Acta"},{"key":"BF03033371_CR55","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.410360612","volume":"36","author":"VM Mann","year":"1994","unstructured":"Mann VM, JM Cooper, SE Daniel, K Srai, P Jenner, CD Marsden and AHV Schapira (1994) Complex I, iron, and ferritin in Parkinson's disease substantia nigra.Ann. Neurol.\n                           36, 871\u2013881.","journal-title":"Ann. Neurol."},{"key":"BF03033371_CR56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","volume":"23","author":"W Markesbery","year":"1997","unstructured":"Markesbery W (1997) Oxidative stress hypothesis in Alzheimer's disease.Free Rad. Biol. Med.\n                           23, 134\u2013147.","journal-title":"Free Rad. Biol. Med."},{"key":"BF03033371_CR57","first-page":"256","volume":"95","author":"CD Marsden","year":"1961","unstructured":"Marsden CD (1961) Pigmentation in the nucleus substantia nigre of mammals.J. Anat.\n                           95, 256\u2013261.","journal-title":"J. Anat."},{"key":"BF03033371_CR58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/mds.870130214","volume":"13","author":"W Martin","year":"1998","unstructured":"Martin W, F Ye and P Allen (1998) Increasing striatal iron content associated with normal aging.Mov. Disord.\n                           13, 281\u2013286.","journal-title":"Mov. Disord."},{"key":"BF03033371_CR59","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"P McGeer","year":"1988","unstructured":"McGeer P, S Itagaki, H Akiyama and E McGeer (1988) Rate of cell death in Parkinson's disease indicates an active neuropathological process.Ann. Neurol.\n                           24, 574\u2013576.","journal-title":"Ann. Neurol."},{"key":"BF03033371_CR60","first-page":"1","volume":"2","author":"H Mochizuki","year":"1993","unstructured":"Mochizuki H, K Nishi and Y Mizuno (1993) Iron-melanin complex is toxic to dopaminergic neurons in nigrostriatal co-culture.Neurodegeneration\n                           2, 1\u20137.","journal-title":"Neurodegeneration"},{"key":"BF03033371_CR61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0197-0186(96)00150-7","volume":"31","author":"D Offen","year":"1997","unstructured":"Offen D, I Ziv, A Barzilai, S Gorodin, E Glater, A Hochman and E Melamed (1997) Dopamine-melanin induces apoptosis in PC12 cells. Possible implications for the etiology of Parkinson's disease.Neurochem. Int.\n                           31, 207\u2013216.","journal-title":"Neurochem. Int."},{"key":"BF03033371_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0304-3940(98)00950-1","volume":"260","author":"D Offen","year":"1999","unstructured":"Offen D, S Gorodin, E Melamed, J Hanania and Z Malik (1999) Dopamine-melanin is actively phagocytized by PC12 cells and cerebellar granular cells: possible implications for the etiology of Parkinson's disease.Neurosci. Lett.\n                           260, 101\u2013104.","journal-title":"Neurosci. Lett."},{"key":"BF03033371_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0891-5849(88)90049-4","volume":"4","author":"B Pilas","year":"1988","unstructured":"Pilas B, T Sarna, B Kalyanaraman and H Swartz (1988) The effect of melanin on iron associated decomposition of hydrogen peroxide.Free Radic. Biol. Med.\n                           4, 285\u2013293.","journal-title":"Free Radic. Biol. Med."},{"key":"BF03033371_CR64","volume-title":"Melanins and Melanogenesis","author":"G Prota","year":"1993","unstructured":"Prota G (1993) Melanins and Melanogenesis (Academic Press; San Diego, New York, Boston, London, Sydney, Tokyo, Toronto)."},{"key":"BF03033371_CR65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, E Sofic, WD Rauch, B Schmidt, GP Reynolds, K Jellinger and MBH Youdim (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.J. Neurochem.\n                           52, 515\u2013520.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archneur.1995.00540300057013","volume":"52","author":"P Ryvlin","year":"1995","unstructured":"Ryvlin P, E Broussolle H Piollet, F Viallet, Y Khalfallah and G Chazot (1995) Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease.Arch. Neurol.\n                           52, 583\u2013588.","journal-title":"Arch. Neurol."},{"key":"BF03033371_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0891-5849(96)00623-5","volume":"23","author":"T Shima","year":"1997","unstructured":"Shima T, T Sarna, H Swartz, A Stroppolo, R Gerbasi and L Zecca (1997) Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study.Free Radic. Biol. Med.\n                           23, 110\u2013119.","journal-title":"Free Radic. Biol. Med."},{"key":"BF03033371_CR68","doi-asserted-by":"publisher","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","volume":"94","author":"MA Smith","year":"1997","unstructured":"Smith MA, PLR Harris, LM Sayre and G Perry (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.Proc. Natl. Acad. Sci. USA\n                           94, 9866\u20139868.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033371_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF01244786","volume":"74","author":"E Sofic","year":"1988","unstructured":"Sofic E, P Riederer, H Heinsen, H Beckman, GP Reynolds, G Hebenstreit and MBH Youdim (1988) Increased iron(III) and total iron content in post mortem substantia nigra of parkinsonian brain.J. Neural Transm.\n                           74, 199\u2013205.","journal-title":"J. Neural Transm."},{"key":"BF03033371_CR70","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1471-4159.1991.tb02017.x","volume":"56","author":"E Sofic","year":"1991","unstructured":"Sofic E, W Paulus, K Jellinger, P Riederer and MBH Youdim (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.J. Neurochem.\n                           56, 978\u2013982.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR71","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1046\/j.1471-4159.1994.62010134.x","volume":"62","author":"J Temlett","year":"1994","unstructured":"Temlett J, J Landsberg, F Watt and G Grime (1994) Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkisonian African Green monkey: evidence from proton microprobe elemental microanalysis.J. Neurochem.\n                           62, 134\u2013146.","journal-title":"J. Neurochem."},{"key":"BF03033371_CR72","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s004010051005","volume":"97","author":"U W\u00fcllner","year":"1999","unstructured":"W\u00fcllner U, J Kornhuber, M Weller, JB Schulz, P-A L\u00f6schmann, P Riederer and T Klockgether (1999) Cell death and apoptosis regulating in Parkinson's disease \u2014 a cautionary note.Acta Neuropathol.\n                           97, 408\u2013412.","journal-title":"Acta Neuropathol."},{"key":"BF03033371_CR73","first-page":"113","volume":"43","author":"MBH Youdim","year":"1994","unstructured":"Youdim MBH, D Ben-Shachar and P Riederer (1994) The enigma of neuromelanin in Parkinson's disease substantia nigra,J. Neural Transm. (Suppl.)\n                           43, 113\u2013122.","journal-title":"J. Neural Transm. (Suppl.)"},{"key":"BF03033371_CR74","first-page":"343","volume":"1271","author":"M Zareba","year":"1995","unstructured":"Zareba M, A Bober, W Korytowski, L Zecca and T Sarna (1995) The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems.Biochem. Biophys. Acta\n                           1271, 343\u2013348.","journal-title":"Biochem. Biophys. Acta"},{"key":"BF03033371_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF02257675","volume":"5","author":"L Zecca","year":"1993","unstructured":"Zecca L and HM Swartz (1993) Total and paramagnetic metals in human substantia nigra and its neuromelanin.J. Neural Transm. (P.D.-Sect.)\n                           5, 203\u2013213.","journal-title":"J. Neural Transm. (P.D.-Sect.)"},{"key":"BF03033371_CR76","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","volume":"76","author":"L Zecca","year":"2001","unstructured":"Zecca L, M Gallorini, V Sch\u00fcmann, A Trautwein, M Gerlach, P Riederer, P Vezzoni and D Tampellini (2001) Iron, neuromelanin and ferritin content in substantia nigra of normal subjects at different ages. Consequences for iron storage and neurodengerative processes.J. Neurochem.\n                           76, 1766\u20131773.","journal-title":"J. Neurochem."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03033371\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T21:14:20Z","timestamp":1652735660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03033371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":76,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["BF03033371"],"URL":"https:\/\/doi.org\/10.1007\/bf03033371","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}